These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 29729168)
1. Changes in cholecystokinin level in patients with gastroesophageal reflux disease on the background of type II diabetes. Sirchak YS; Stan MP; Brych VV Wiad Lek; 2018; 71(2 pt 1):333-336. PubMed ID: 29729168 [TBL] [Abstract][Full Text] [Related]
2. INFLUENCE OF URSODEOXYCHOLIC ACID ON THE CHOLECYSTOKININ LEVELS IN PATIENTS WITH GASTRO-ESOPHAGEAL REFLUX DISEASE AND TYPE 2 DIABETES MELLITUS. Sirchak Y; Derbak M; Stan M; Petrichko O Georgian Med News; 2021 Mar; (312):67-71. PubMed ID: 33964829 [TBL] [Abstract][Full Text] [Related]
3. Duodenal lipid-induced symptom generation in gastroesophageal reflux disease: role of apolipoprotein A-IV and cholecystokinin. van Boxel OS; ter Linde JJ; Oors J; Otto B; Feinle-Bisset C; Smout AJ; Siersema PD Neurogastroenterol Motil; 2012 Apr; 24(4):350-e168. PubMed ID: 22300015 [TBL] [Abstract][Full Text] [Related]
4. CHANGES IN SERUM GHRELIN AND ITS RELATIONSHIP WITH OF BODY MASS INDEX IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE AND SPONDYLOARTHRITIS. Sirchak YS; Tsioka SA; Chobej AS; Bedey NV; Borisova IS Wiad Lek; 2022; 75(4 pt 2):982-986. PubMed ID: 35633329 [TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal reflux disease related to diabetes: Analysis of 241 cases with type 2 diabetes mellitus. Nishida T; Tsuji S; Tsujii M; Arimitsu S; Sato T; Haruna Y; Miyamoto T; Kanda T; Kawano S; Hori M J Gastroenterol Hepatol; 2004 Mar; 19(3):258-65. PubMed ID: 14748871 [TBL] [Abstract][Full Text] [Related]
6. CHANGES IN SERUM SOMATOSTATIN AND GASTRIN LEVELS IN PATIENTS AFTER CHOLECYSTECTOMY AND GASTROESOPHAGEAL REFLUX DISEASE. Sirchak YS; Kydybyts SS; Bedey NV; Chendey VI; Stan MP; Chobej SM Wiad Lek; 2023; 76(3):548-553. PubMed ID: 37057778 [TBL] [Abstract][Full Text] [Related]
7. [Morphological peculiarities of esophageal mucosa in patients with gastroesophageal reflux disease and type ii diabetes mellitus]. Fadeenko GD; Frolova-Romaniuk EIu; Gal'chinskaia VIu Georgian Med News; 2014 Feb; (227):28-31. PubMed ID: 24632643 [TBL] [Abstract][Full Text] [Related]
8. Gastric greater curvature plication combined with Nissen fundoplication in the treatment of gastroesophageal reflux disease and obesity. Ospanov O; Maleckas A; Orekeshova A Medicina (Kaunas); 2016; 52(5):283-290. PubMed ID: 27707580 [TBL] [Abstract][Full Text] [Related]
9. The effect of cholecystectomy on plasma cholecystokinin. McDonnell CO; Bailey I; Stumpf T; Walsh TN; Johnson CD Am J Gastroenterol; 2002 Sep; 97(9):2189-92. PubMed ID: 12358231 [TBL] [Abstract][Full Text] [Related]
10. [FEATURES MANIFESTATIONS COMORBID CURRENTS OF GASTROESOPHAGEAL REFLUX DISEASE AND ARTERIAL HYPERTENSION DEPENDING ON THE DEGREE OF ARTERIAL HYPERTENSION]. Fadieienko G; Gridniev O Georgian Med News; 2015 Nov; (248):21-9. PubMed ID: 26656546 [TBL] [Abstract][Full Text] [Related]
11. Lack of relationship between blood glucose-lowering activity of colestimide and serum cholecystokinin (CCK) concentrations in patients with type 2 diabetes. Suzuki T; Oba K; Norose J; Yoshimatsu H; Sekimizu K; Futami-Suda S; Ouchi M; Suzuki K; Kigawa Y; Nakano H J Nippon Med Sch; 2008 Apr; 75(2):111-5. PubMed ID: 18475032 [TBL] [Abstract][Full Text] [Related]
12. Eating Behaviours and Prevalence of Gastroesophageal Reflux Disease in Japanese Adult Patients With Type 2 Diabetes Mellitus: The Dogo Study. Takeshita E; Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Senba H; Yamamoto Y; Arimitsu E; Yagi S; Utsunomiya H; Tanaka K; Ikeda Y; Matsuura B; Miyake Y; Hiasa Y Can J Diabetes; 2018 Jun; 42(3):308-312. PubMed ID: 29056257 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of GERD in Type II Diabetes Mellitus Patients Admitted in A Tertiary Care Hospital of Bangladesh. Rouf MA; Khan M; Sharif JU; Karim MR; Rahman MM; Ahmed H; Pandit H; Khan AU; Rahman MA; Talukder RK; Parveen R; Akhter H Mymensingh Med J; 2017 Oct; 26(4):710-715. PubMed ID: 29208856 [TBL] [Abstract][Full Text] [Related]
14. The effects of intraduodenal nutrient infusion on serum CCK, LES pressure, and gastroesophageal reflux. Lacy BE; Carter J; Weiss JE; Crowell MD Neurogastroenterol Motil; 2011 Jul; 23(7):631-e256. PubMed ID: 21435103 [TBL] [Abstract][Full Text] [Related]
15. Review of gastroesophageal reflux disease (GERD) in the diabetic patient. Punjabi P; Hira A; Prasad S; Wang X; Chokhavatia S J Diabetes; 2015 Sep; 7(5):599-609. PubMed ID: 25706050 [TBL] [Abstract][Full Text] [Related]
16. Clinical Relevance of Blood Glucose and Gastroesophageal Reflux Symptoms to Depressive Status in Patients with Type 2 Diabetes Mellitus. Honda H; Hanayama Y; Obika M; Hasegawa K; Hamahara J; Kishida M; Hagiya H; Ogawa H; Kataoka H; Otsuka F Acta Med Okayama; 2020 Feb; 74(1):33-40. PubMed ID: 32099246 [TBL] [Abstract][Full Text] [Related]
17. Gastroesophageal reflux disease in patients with diabetes: preliminary study. Fujiwara M; Miwa T; Kawai T; Odawara M J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():31-5. PubMed ID: 25827801 [TBL] [Abstract][Full Text] [Related]
18. [Comparative data of prokinetics in treatment of gastroesophageal reflux disease in patients with diabetes]. Fedorchenko IuL Eksp Klin Gastroenterol; 2013; (5):42-8. PubMed ID: 24501946 [TBL] [Abstract][Full Text] [Related]
19. The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease. Hershcovici T; Jha LK; Gadam R; Cui H; Gerson L; Thomson S; Fass R J Clin Gastroenterol; 2012 Sep; 46(8):662-8. PubMed ID: 22858518 [TBL] [Abstract][Full Text] [Related]
20. CHANGES IN PROSTAGLANDIN LEVELS IN BLOOD SERUM OF PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE ON THE BACKGROUND OF THE OSTEOCHONDROSIS OF THE SPINE AND OBESITY. Sirchak YS; Boldizhar OO; Filak YF; Ustych OV; Koval VY; Barani VY; Borisova IS Wiad Lek; 2022; 75(10):2497-2500. PubMed ID: 36472287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]